LMP2-CfoI allele | |||
A (%) | B (%) | ||
Guadalajara4-150 | |||
Juveniles | |||
AAU+ | 1 (25) | 3 (75) | |
AAU− | 3 (10) | 27 (90) | |
Adults | |||
AAU+ | 6 (33.3) | 12 (66.7) | |
AAU− | 21 (16.4) | 107 (83.6) | |
Mexico City4-151 | |||
Juveniles | |||
AAU+ | 8 (33.3) | 16 (66.7) | |
AAU− | 14 (17.5) | 66 (82.5) | |
Adults | |||
AAU+ | 2 (33.3) | 4 (66.7) | |
AAU− | 9 (18) | 41 (82) |
↵4-150 Stratified exact OR = 2.58 (95% CI, 0.80, 7.62; p = 0.12).
↵4-151 Stratified exact OR = 2.31 (95% CI, 0.84, 6.12; p = 0.11).
Combined population stratified exact OR = 2.51 (95% CI, 1.21, 5.09; p = 0.013). OR = The exact conditional maximum likelihood estimates, stratified by age at onset of disease, for the odds ratio relating LMP2A allelic frequency and history of AAU.